Colombia vs Netherlands: Previously treated cases tested for RR-/MDR-TB
Colombia
75.0%
in 2024
Netherlands
75.0%
in 2024
Colombia rank
123rd
Netherlands rank
123rd
Previously treated cases tested for RR-/MDR-TB over time
- Colombia
- Netherlands
How they compare
Colombia currently reports 75.0% against 75.0% in Netherlands, a difference of 0.0%.
The two have swapped places 4 times across 17 shared years of data; in 2006 it was Netherlands ahead.
Colombia ranks 123rd and Netherlands ranks 123rd of 180 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Colombia | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.3% | 75.0% | 4.7% | Netherlands |
| 2010s | 41.5% | 67.2% | 25.7% | Netherlands |
| 2020s | 56.5% | 72.2% | 15.8% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Colombia or Netherlands?
- Colombia, at 75.0% against 75.0% in Netherlands as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Colombia and Netherlands?
- 0.0%, with Colombia ahead.
- How many years of comparable data are there for Colombia and Netherlands?
- 17 years are reported by both, from 2006 to 2024.
- How do Colombia and Netherlands rank globally for previously treated cases tested for rr-/mdr-tb?
- Colombia ranks 123rd and Netherlands ranks 123rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.